(Q40595769)

21 September 2017

Neprilysin regulates amyloid Beta peptide levels (English)

1 reference

21 September 2017

3

Edward Rockenstein

1 reference

21 September 2017

7

Eliezer Masliah

1 reference

21 September 2017

5

Fred H Gage

1 reference

21 September 2017

Robert A Marr

1

1 reference

21 September 2017

Hanjun Guan

2

1 reference

21 September 2017

Mark Kindy

4

1 reference

21 September 2017

Inder Verma

6

1 reference

21 September 2017

Louis B Hersh

8

1 reference

21 September 2017

1 January 2004

1 reference

Journal of Molecular Neuroscience

21 September 2017

1 reference

21 September 2017

22

1 reference

21 September 2017

5-11

1 reference

21 September 2017

1-2

1 reference

https://scigraph.springernature.com/pub.10.1385/jmn:22:1-2:5

21 September 2017

0 references

cites work

Abeta immunization and anti-Abeta antibodies: potential therapies for the prevention and treatment of Alzheimer's disease

1 reference

12 December 2020

Peptidases, proteases and amyloid beta-peptide catabolism

1 reference

12 December 2020

Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.

1 reference

12 December 2020

Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain

1 reference

12 December 2020

Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).

1 reference

12 December 2020

Regulation of amyloid beta-peptide levels by enzymatic degradation.

1 reference

12 December 2020

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

12 December 2020

Development of a self-inactivating lentivirus vector.

1 reference

12 December 2020

Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism

1 reference

12 December 2020

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

1 reference

12 December 2020

A third-generation lentivirus vector with a conditional packaging system

1 reference

12 December 2020

Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease

1 reference

12 December 2020

Degradation of enkephalins: the search for an enkephalinase

1 reference

12 December 2020

Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.

1 reference

12 December 2020

Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide.

1 reference

12 December 2020

Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:22:1-2:5

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference